Monoclonal gammopathy of undetermined significance overview: Difference between revisions
Created page with "__NOTOC__ {{ Monoclonal gammopathy of undetermined significance }} {{CMG}} ==Overview== '''Monoclonal gammopathy of undetermined significance''' is a condition in which a lo..." |
No edit summary |
||
| Line 2: | Line 2: | ||
{{ Monoclonal gammopathy of undetermined significance }} | {{ Monoclonal gammopathy of undetermined significance }} | ||
{{CMG}} | {{CMG}}; {{AE}} {{OK}} | ||
==Overview== | ==Overview== | ||
'''Monoclonal gammopathy of undetermined significance''' is a condition in which a low or non-quantifiable level of a [[monoclonal]] [[paraprotein]] is detected in the blood by means of [[protein electrophoresis]]. In addition, some patients develop a [[polyneuropathy]] (damage to peripheral nerves) or other problems related to the secreted antibody. MGUS is distinct from [[multiple myeloma]], as described below. | '''Monoclonal gammopathy of undetermined significance''' is a condition in which a low or non-quantifiable level of a [[monoclonal]] [[paraprotein]] is detected in the blood by means of [[protein electrophoresis]]. In addition, some patients develop a [[polyneuropathy]] (damage to peripheral nerves) or other problems related to the secreted antibody. MGUS is distinct from [[multiple myeloma]], as described below. ==Overview== | ||
==Historical Perspective== | |||
==Classification== | |||
==Pathophysiology== | |||
==Causes== | |||
==Differentiating Xyz from Other Diseases== | |||
==Epidemiology and Demographics== | |||
==Risk Factors== | |||
==Screening== | |||
==Natural History, Complications, and Prognosis== | |||
==Diagnosis== | |||
===Diagnostic Study of Choice=== | |||
===History and Symptoms=== | |||
===Physical Examination=== | |||
===Laboratory Findings=== | |||
===Electrocardiogram=== | |||
===X-ray=== | |||
===Echocardiography and Ultrasound=== | |||
===CT scan=== | |||
===MRI=== | |||
===Other Imaging Findings=== | |||
===Other Diagnostic Studies=== | |||
==Treatment== | |||
===Medical Therapy=== | |||
=== Interventions === | |||
===Surgery=== | |||
===Primary Prevention=== | |||
===Secondary Prevention=== | |||
==References== | ==References== | ||
Revision as of 16:02, 14 August 2018
|
Monoclonal gammopathy of undetermined significance Microchapters |
|
Differentiating Monoclonal gammopathy of undetermined significance from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Monoclonal gammopathy of undetermined significance overview On the Web |
|
American Roentgen Ray Society Images of Monoclonal gammopathy of undetermined significance overview |
|
FDA on Monoclonal gammopathy of undetermined significance overview |
|
on Monoclonal gammopathy of undetermined significance overview |
|
Monoclonal gammopathy of undetermined significance overview in the news |
|
Blogs on Monoclonal gammopathy of undetermined significance overview |
|
Directions to Hospitals Treating Monoclonal gammopathy of undetermined significance |
|
Risk calculators and risk factors for Monoclonal gammopathy of undetermined significance overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
Monoclonal gammopathy of undetermined significance is a condition in which a low or non-quantifiable level of a monoclonal paraprotein is detected in the blood by means of protein electrophoresis. In addition, some patients develop a polyneuropathy (damage to peripheral nerves) or other problems related to the secreted antibody. MGUS is distinct from multiple myeloma, as described below. ==Overview==